TGFBI Antikörper (AA 119-131)
-
- Target Alle TGFBI Antikörper anzeigen
- TGFBI (Transforming Growth Factor, beta-Induced, 68kDa (TGFBI))
-
Bindungsspezifität
- AA 119-131
-
Reaktivität
- Human, Maus, Ratte, Hund, Rind (Kuh), Pferd, Kaninchen, Fledermaus, Schwein
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TGFBI Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marke
- IHC-plus™
- Spezifität
- Human TGFBI.
- Homologie
- Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Mouse, Rat, Elephant, Panda, Bovine, Dog, Bat, Horse, Rabbit, Pig, Opossum (100%) Marmoset, Platypus (92%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide C-QLYTDRTEKLRPE from an internal region of human TGFBI (NP_000349.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Mouse, Rat, Elephant, Panda, Bovine, Dog, Bat, Horse, Rabbit, Pig, Opossum (100%), Marmoset, Platypus (92%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product TGFBI Primärantikörper
-
-
- Applikationshinweise
-
Approved: IHC, IHC-P (3.75 μg/mL), Peptide-ELISA (1:32000), WB (0.2 - 0.5 μg/mL)
Usage: Peptide ELISA: antibody detection limit dilution 1:32000. Western blot: Approx 70 kDa band observed in Human, Mouse and Rat Kidney lysates (calculated MW of 74.7 kDa according to Human NP_000349.1). Recommended concentration: 0.2-0.5 μg/mL. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Tris-buffered saline, pH 7.3, 0.5 % BSA, 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze-thaw cycles.
-
- Target
- TGFBI (Transforming Growth Factor, beta-Induced, 68kDa (TGFBI))
- Andere Bezeichnung
- TGFBI (TGFBI Produkte)
- Synonyme
- TGFBI antikoerper, BIGH3 antikoerper, CDB1 antikoerper, CDG2 antikoerper, CDGG1 antikoerper, CSD antikoerper, CSD1 antikoerper, CSD2 antikoerper, CSD3 antikoerper, EBMD antikoerper, LCD1 antikoerper, 68kDa antikoerper, AI181842 antikoerper, AI747162 antikoerper, Beta-ig antikoerper, big-h3 antikoerper, Big-h3 antikoerper, MP70 antikoerper, MP78 antikoerper, hm:zeh0933 antikoerper, wu:fa13f05 antikoerper, zgc:110495 antikoerper, transforming growth factor beta induced antikoerper, transforming growth factor, beta induced antikoerper, transforming growth factor, beta-induced antikoerper, TGFBI antikoerper, Tgfbi antikoerper, tgfbi antikoerper
- Hintergrund
-
Name/Gene ID: TGFBI
Family: TGF beta
Synonyms: TGFBI, BIGH3, Beta ig-h3, CDG2, CSD, CSD2, CSD3, CDGG1, EBMD, Kerato-epithelin, LCD1, RGD-CAP, CDB1, CSD1 - Gen-ID
- 7045
- NCBI Accession
- NP_000349
- UniProt
- Q15582
-